In addition, according to the relative expression level of FGD5-AS1, the 80 patients in GC cohort 2 were divided into the high FGD5-AS1 expression group (n = 53) and the low FGD5-AS1 expression group (n = 27, Fig. 3g). This evidence concerns the gene FGD5 and gastric cancer.